AARS2 Gene Leukoencephalopathy progressive with ovarian failure Genetic Test sale cost 4400 AED
FAM126A Gene Leukodystrophy hypomyelinating type 5 Genetic Test sale cost 4400 AED FAM126A Gene Leukodystrophy hypomyelinating type 5 Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
POMK Gene Limb-girdle muscular dystrophy autosomal recessive type 12C Genetic Test sale cost 4400 AED POMK Gene Limb-girdle muscular dystrophy autosomal recessive type 12C Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

AARS2 Gene Leukoencephalopathy progressive with ovarian failure Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

AARS2 gene leukoencephalopathy is a rare genetic disorder characterized by progressive damage to the white matter of the brain, known as leukoencephalopathy, and is often associated with premature ovarian failure. This condition is caused by mutations in the AARS2 gene, which plays a critical role in protein synthesis within mitochondria. Symptoms can vary but often include neurological impairments, muscle weakness, and in females, early menopause or infertility due to ovarian failure.

To diagnose this condition, genetic testing is essential. DNA Labs UAE offers a specific genetic test aimed at identifying mutations in the AARS2 gene, which can confirm the diagnosis of AARS2 gene leukoencephalopathy. This test is crucial for individuals presenting symptoms of the disorder or for those with a family history of leukoencephalopathy and ovarian failure, as it can provide a definitive diagnosis and guide treatment and management options.

The cost of the AARS2 gene leukoencephalopathy genetic test at DNA Labs UAE is 4400 AED. The test involves collecting a DNA sample, typically through a blood draw, which is then analyzed in the laboratory for the presence of mutations in the AARS2 gene. Results from this test can help healthcare providers develop a personalized treatment plan and offer genetic counseling for affected individuals and their families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

AARS2 Gene Leukoencephalopathy progressive with ovarian failure Genetic Test

Test Name: AARS2 Gene Leukoencephalopathy progressive with ovarian failure Genetic Test

Components: NGS Technology

Price: 4400.0 AED

Sample Condition: Blood

Report Delivery: 3 to 4 Weeks

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for AARS2 Gene Leukoencephalopathy, progressive, with ovarian failure NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with AARS2 Gene Leukoencephalopathy, progressive, with ovarian failure.

Test Details

AARS2 gene leukoencephalopathy, progressive, with ovarian failure is a rare genetic disorder characterized by progressive degeneration of the white matter in the brain (leukoencephalopathy) and premature ovarian failure. It is caused by mutations in the AARS2 gene, which provides instructions for making the alanyl-tRNA synthetase 2 enzyme.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of AARS2 gene leukoencephalopathy, progressive, with ovarian failure, NGS genetic testing can be used to identify mutations or variants in the AARS2 gene that may be responsible for the condition.

NGS genetic testing is a powerful tool that allows for the analysis of a large number of genes in a more efficient and cost-effective manner compared to traditional sequencing methods. It can help in diagnosing genetic disorders, providing information about disease prognosis, and guiding treatment decisions.

If a person presents with symptoms suggestive of AARS2 gene leukoencephalopathy, progressive, with ovarian failure, NGS genetic testing can be performed to confirm the diagnosis by identifying pathogenic mutations in the AARS2 gene. This information can then be used for genetic counseling, family planning, and potentially guiding treatment options.

Test Name AARS2 Gene Leukoencephalopathy progressive with ovarian failure Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for AARS2 Gene Leukoencephalopathy, progressive, with ovarian failure NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with AARS2 Gene Leukoencephalopathy, progressive, with ovarian failure
Test Details

AARS2 gene leukoencephalopathy, progressive, with ovarian failure is a rare genetic disorder characterized by progressive degeneration of the white matter in the brain (leukoencephalopathy) and premature ovarian failure. It is caused by mutations in the AARS2 gene, which provides instructions for making the alanyl-tRNA synthetase 2 enzyme.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of AARS2 gene leukoencephalopathy, progressive, with ovarian failure, NGS genetic testing can be used to identify mutations or variants in the AARS2 gene that may be responsible for the condition.

NGS genetic testing is a powerful tool that allows for the analysis of a large number of genes in a more efficient and cost-effective manner compared to traditional sequencing methods. It can help in diagnosing genetic disorders, providing information about disease prognosis, and guiding treatment decisions.

If a person presents with symptoms suggestive of AARS2 gene leukoencephalopathy, progressive, with ovarian failure, NGS genetic testing can be performed to confirm the diagnosis by identifying pathogenic mutations in the AARS2 gene. This information can then be used for genetic counseling, family planning, and potentially guiding treatment options.

SKU: TEST-1524 Category:

Related products